Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2012

01-05-2012 | Research Articles

Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls

Authors: Basak Oven Ustaalioglu, Ahmet Bilici, Serif Ercan, Asuman Orcun, Mesut Seker, Alper Ozkan, Recep Ustaalioglu, Mahmut Gumus

Published in: Clinical and Translational Oncology | Issue 5/2012

Login to get access
Metadata
Title
Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls
Authors
Basak Oven Ustaalioglu
Ahmet Bilici
Serif Ercan
Asuman Orcun
Mesut Seker
Alper Ozkan
Recep Ustaalioglu
Mahmut Gumus
Publication date
01-05-2012
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0808-0

Other articles of this Issue 5/2012

Clinical and Translational Oncology 5/2012 Go to the issue

Brief Research Articles

A prospective biological study in relation to a family with Li-Fraumeni syndrome

Educational Series

Advances in cutaneous melanoma

Research Articles

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

Educational Series

Need to implement a coordinated and multidisciplinary care in the Spanish population at increased risk for colorectal cancer

Special Article

Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

Research Articles

Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits